Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded a new Study Status section with updates on 2025-12-24 and 2025-12-08, and deleted an entry on 2025-09-03.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded a new Revision: v3.3.3 to the Record History. Removed the HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry (v3.3.2) was added to the history, and the previous entry (v3.2.0) was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedBanner about government funding and operating status was removed from the page. This banner did not affect core trial data or functionality.SummaryDifference0.4%

- Check69 days agoChange DetectedA new history entry appears in the Study Record History; this is a routine log update and the rest of the page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference9%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.